Mass-Screening of Curarimimetic Neurotoxin Antagonists
Abstract
The third year of the contract period was devoted to testing several ion flux protocols for the distinction between toxic and therapeutic blockers of curarimimetric neurotoxins. First a cell line suitable for acetylcholine receptor channel analysis was identified; among several rodent and human lines the murine tumor line BC3-H1 was selected because of its high receptor content. After determining optimal culture conditions for this line attempts were made to miniaturize the flux assay; we were able to perform 86Rb flux measurement in standard 24-well multititer plates. Keywords: Neurotoxin; Acetylcholine receptor; Ion flux; Antidote.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 10, 1990
- Accession Number
- ADA222729
Entities
People
- Jakob Schmidt
Organizations
- State University of New York